PRO2 Elite Plus Oxygen Analyzer (PRO2PLUS-1)
Analyzer, Gas, Oxygen, Gaseous-Phase. 510(k) K261389, from Salter Labs (El Paso, TX). Product code CCL, class 2.
As of Nov 17, 2026, K261389 is an FDA 510(k) held by Salter Labs, substantially equivalent on Jul 30, 2026 after 93 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Jul 30, 2026
- Review time: 93 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFPlease type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. K261389 ? Please provide the device trade name(s). ? PRO2 Elite Plus Oxygen Analyzer (PRO2PLUS-1) Please provide your Indications for Use below. ? Attachment 10.2 510(k) Summary Contents I. Manufacturer: Salter Labs... 2 II. Subject Device ... 2 III.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- ULTRAMAXO2 Oxygen AnalyerK112402 · Maxtec, LLC · Dec 14, 2011
Other CCL Clearances
The newest 510(k)s for the same product code; their median review was 112 days; see every CCL device- OxyMinder Pro (10310)K251245 · Bio-Med Device, Inc. · Aug 11, 2025
- Smart Check O2 (MA0236)K250002 · Life Spark Medical, LLC · Apr 24, 2025
- Maxtec MaxO2 ME+pK221734 · Maxtec, LLC · Apr 1, 2023
- Percent Oxygen SensorsK213933 · Careox, LLC · Aug 19, 2022
- OxyMinderK213948 · Bio-Med Devices, Inc. · Mar 17, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 28, 2026
- Review panel
- Anesthesiology
- Regulation
- 21 CFR 868.1720
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files